Drug repurposing of triazoles against mucormycosis using molecular docking: a short communication

S Mhatre, V Patravale - Computers in Biology and Medicine, 2021 - Elsevier
Background Mucormycosis, a fungal infection caused by Rhizopus species is on the rise in
COVID-19 patients as a result of their suppressed immunity. The current therapies include …

[HTML][HTML] In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis

P Madanagopal, N Ramprabhu… - Bulletin of the National …, 2022 - Springer
Background During the second wave of the COVID-19 pandemic, an unusual increase in
cases of mucormycosis was observed in India, owing to immunological dysregulation …

[HTML][HTML] Targeting mucormycosis polyprotein (RVT_1 region) through antifungal phytochemicals: An in-silico perspective

A Banik, SR Ahmed, H Marma, S Sinha… - Informatics in Medicine …, 2022 - Elsevier
Mucormycosis has become a global issue due to its potential to infect and destroy organs,
as well as its high fatality rate. Co-infecting with Covid 19 or when infecting after Covid 19, it …

Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents

MK Hussain, S Ahmed, A Khan, AJ Siddiqui… - European Journal of …, 2023 - Elsevier
Mucormycosis is a fungal infection which got worsens with time if not diagnosed and treated.
The current COVID-19 pandemic has association with fungal infection specifically with …

[HTML][HTML] Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box®: In Vitro and In Silico Analyses

MIDS Xisto, R Rollin-Pinheiro, Y de Castro-Almeida… - Journal of Fungi, 2023 - mdpi.com
Mucormycosis is considered concerning invasive fungal infections due to its high mortality
rates, difficult diagnosis and limited treatment approaches. Mucorales species are highly …

[HTML][HTML] Inhibitory effect of lupeol, quercetin, and solasodine on Rhizopus oryzae: A molecular docking and dynamic simulation study

D Arumuganainar, PK Yadalam, KJ Alzahrani… - Journal of Infection and …, 2023 - Elsevier
Background Mucormycosis is an infection caused by fungi belonging to the order Mucorales.
Rhizopus oryzae is one of the most prevalent organisms identified in mucormycosis patients …

[HTML][HTML] Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review

M Faiyazuddin, A Sophia, S Ashique… - Frontiers in …, 2023 - frontiersin.org
The outbreak of a fatal black fungus infection after the resurgence of the cadaverous COVID-
19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new …

[HTML][HTML] Mucormycosis amid COVID-19 crisis: pathogenesis, diagnosis, and novel treatment strategies to combat the spread

S Dogra, A Arora, A Aggarwal, G Passi… - Frontiers in …, 2022 - frontiersin.org
The havoc unleashed by COVID-19 pandemic has paved way for secondary ominous fungal
infections like Mucormycosis. It is caused by a class of opportunistic pathogens from the …

[HTML][HTML] Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic

A Sharma, A Goel - Folia Microbiologica, 2022 - Springer
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

Comprehensive Review on the Virulence Factors and Therapeutic Strategies with the Aid of Artificial Intelligence against Mucormycosis

M Tanwar, A Singh, TP Singh, S Sharma… - ACS Infectious …, 2024 - ACS Publications
Mucormycosis, a rare but deadly fungal infection, was an epidemic during the COVID-19
pandemic. The rise in cases (COVID-19-associated mucormycosis, CAM) is attributed to …